al of Arth rn ri u ti o s J Akhtar et al., J Arthritis 2017, 6:6 Journal of Arthritis DOI: 10.4172/2167-7921.1000256 ISSN: 2167-7921 Review Article Open Access Role of Hijama’ (Cupping Therapy) in the Management of Niqras (Gouty Arthritis) Hilal Akhtar1, Mohammad Rashid2*, Misbahuddin Siddiqi3 and Qazi Zaid Ahmad4 1Amraz-e-jild Wa Tazineeyat (Skin), RUMC, Jaipur, Rajasthan, India 2Department of Saidla (Pharmacy), Faculty of Unani Medicine, AMU, Aligarh, India 3Department of Moalijat, Faculty of Unani Medicine, AMU, Aligarh, India 4Department of Saidla (Pharmacy), Faculty of Unani Medicine, AMU, Aligarh, India *Corresponding author: Mohammad Rashid, Department of Saidla (Pharmacy) Faculty of Unani Medicine, AMU, Aligarh, India, Tel: +919760518279; E-mail:
[email protected] Received date: October 18, 2017; Accepted date: November 01, 2017; Published date: November 04, 2017 Copyright: © 2017 Akhtar H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Gout is a potentially progressive and debilitating form of chronic inflammatory arthritis caused by the deposition of monosodium urate crystals in synovial fluid and other tissues, characterized by sudden & severe episode of pain, warmth and swelling in a joint. People suffering from recurrent attacks frequently experience pain and disability, reduced health-related quality of life and productivity and increased morbidity. NSAIDs, colchicines, glucocorticoids, uric acid lowering agent like uricostatic drugs (allopurinol, a xanthine oxidase inhibitor), Uricosuric drugs (Probenecid) are very effective but risky in patients having pre-existing renal, cardiovascular, gastrointestinal and metabolic disorders.